PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
16-May-2024 Newron reports compelling additional data documenting the efficacy of evenamide in pivotal study 008A in poorly responding schizophrenia patients Newron Pharmaceuticals
15-May-2024 Significant and Sustained Improvements in Renal Function Reported for Adults with Chronic Hypoparathyroidism Treated with TransCon™ PTH (Palopegteriparatide): 2-year Results from Phase 3 PaTHway Trial Ascendis Pharma A/S
15-May-2024 HUTCHMED Initiates the RAPHAEL Registrational Phase III Trial of HMPL-306 for Patients with IDH1- and/or IDH2-Mutated Relapsed/Refractory Acute Myeloid Leukemia in China HUTCHMED
15-May-2024 HUTCHMED Initiates Phase II/III Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma in Collaboration with Hengrui HUTCHMED
15-May-2024 Evotec SE to announce results for first quarter 2024 on 22 may 2024 Evotec SE
15-May-2024 Cantourage Group SE records strong growth in revenue and EBITDA in the break-even range in 2023. Strong growth since the partial legalisation of cannabis came into force. Cantourage Group SE
15-May-2024 Ad-hoc: Cantourage Group SE records strong growth in 2024 since the partial legalisation of cannabis came into force Cantourage Group SE
15-May-2024 Strong organic growth in core markets underscores resilience of Dermapharm Holding SE's corporate strategy Dermapharm Holding SE
15-May-2024 MS Pharma becomes Partner for the Commercialization of FYB203, Formycon’s Biosimilar Candidate to Eylea® (Aflibercept), in the MENA Region Formycon AG
14-May-2024 SCHOTT Pharma confirms outlook for FY 24 based on Q2 results; FY 25 impacted by slower growth from syringes SCHOTT Pharma AG & Co. KGaA
14-May-2024 SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma see FY 25 impacted by slower growth from syringes SCHOTT Pharma AG & Co. KGaA
14-May-2024 InsightRX Continues Momentum in Precision Dosing with Client Growth, New Scientific Breakthroughs InsightRX
14-May-2024 DEFENCE THERAPEUTICS STRENGTHENS AND EXPANDS GLOBAL PATENT PROTECTION ON KEY TECHNOLOGIES Defence Therapeutics Inc.
14-May-2024 Eckert & Ziegler with significant increase in sales (+17%) and adjusted EBIT (+41%) in Q1. Forecast 2024 confirmed. Eckert & Ziegler SE
14-May-2024 PharmaSGP continues dynamic business development with significant revenues growth in Q1 2024 PharmaSGP Holding SE
14-May-2024 Q1 2024 Qualitative Update: Performance In Line with Expectations for Full-Year 2024 Lonza Group AG
14-May-2024 DocMorris AG: DocMorris announces results of Tender Offer DocMorris AG
14-May-2024 Biophytis announces the design of its phase 2 OBA clinical study in obesity Biophytis
13-May-2024 Newron reports compelling additional data documenting the efficacy of evenamide in pivotal study 008A in poorly responding schizophrenia patients Newron Pharmaceuticals S.p.A.
10-May-2024 MODERNA WELCOMES THE SECRETARY OF STATE FOR HEALTH AND SOCIAL CARE TO THE MODERNA INNOVATION AND TECHNOLOGY CENTRE IN OXFORDSHIRE Moderna